EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL

Elsa Mondou; Guntis Karelis; Rodica Balasa; Jan L. De Bleecker; Philip Van Damme; Emmeline Lagrange; Jeannine Heckmann; Michael Nicolle; Crisandra Vilciu; Vera Bril; Rhonda Griffin; Junliang Chen; Beatriz Garcia; Sandra Camprubi; Jaume Ayguasanosa

doi:10.1002/mus.26647

EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL

Elsa Mondou, Guntis Karelis, Rodica Balasa, Jan L. De Bleecker, Philip Van Damme, Emmeline Lagrange, Jeannine Heckmann, Michael Nicolle, Crisandra Vilciu, Vera Bril, Rhonda Griffin, Junliang Chen, Beatriz Garcia, Sandra Camprubi, Jaume Ayguasanosa

Rīga Stradiņš University

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S47-S47
Journal	Muscle and Nerve
Volume	60
Issue number	S1
DOIs	https://doi.org/10.1002/mus.26647
Publication status	Published - Sept 2019
Event	Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine - Austin, United States Duration: 16 Oct 2019 → 19 Oct 2019

Keywords*

neurosciencies
Neurology

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

10.1002/mus.26647

https://onlinelibrary.wiley.com/toc/10974598/2019/60/S1

Cite this

Mondou, E., Karelis, G., Balasa, R., De Bleecker, J. L., Van Damme, P., Lagrange, E., Heckmann, J., Nicolle, M., Vilciu, C., Bril, V., Griffin, R., Chen, J., Garcia, B., Camprubi, S., & Ayguasanosa, J. (2019). EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL. Muscle and Nerve, 60(S1), S47-S47. https://doi.org/10.1002/mus.26647

@article{1896a638453c48adafc04f82c3e5286e,

title = "EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL",

keywords = "neurosciencies, Neurology",

author = "Elsa Mondou and Guntis Karelis and Rodica Balasa and \{De Bleecker\}, \{Jan L.\} and \{Van Damme\}, Philip and Emmeline Lagrange and Jeannine Heckmann and Michael Nicolle and Crisandra Vilciu and Vera Bril and Rhonda Griffin and Junliang Chen and Beatriz Garcia and Sandra Camprubi and Jaume Ayguasanosa",

year = "2019",

month = sep,

doi = "10.1002/mus.26647",

language = "English",

volume = "60",

pages = "S47--S47",

journal = "Muscle and Nerve",

issn = "0148-639X",

publisher = "John Wiley \& Sons Inc.",

number = "S1",

note = "Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine, AANEM ; Conference date: 16-10-2019 Through 19-10-2019",

}

Mondou, E, Karelis, G, Balasa, R, De Bleecker, JL, Van Damme, P, Lagrange, E, Heckmann, J, Nicolle, M, Vilciu, C, Bril, V, Griffin, R, Chen, J, Garcia, B, Camprubi, S & Ayguasanosa, J 2019, 'EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL', Muscle and Nerve, vol. 60, no. S1, pp. S47-S47. https://doi.org/10.1002/mus.26647

EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL. / Mondou, Elsa; Karelis, Guntis; Balasa, Rodica et al.
In: Muscle and Nerve, Vol. 60, No. S1, 09.2019, p. S47-S47.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS

T2 - Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine

AU - Mondou, Elsa

AU - Karelis, Guntis

AU - Balasa, Rodica

AU - De Bleecker, Jan L.

AU - Van Damme, Philip

AU - Lagrange, Emmeline

AU - Heckmann, Jeannine

AU - Nicolle, Michael

AU - Vilciu, Crisandra

AU - Bril, Vera

AU - Griffin, Rhonda

AU - Chen, Junliang

AU - Garcia, Beatriz

AU - Camprubi, Sandra

AU - Ayguasanosa, Jaume

PY - 2019/9

Y1 - 2019/9

KW - neurosciencies

KW - Neurology

UR - https://www.webofscience.com/wos/alldb/full-record/WOS:000480524300094

U2 - 10.1002/mus.26647

DO - 10.1002/mus.26647

M3 - Meeting Abstract

SN - 0148-639X

VL - 60

SP - S47-S47

JO - Muscle and Nerve

JF - Muscle and Nerve

IS - S1

Y2 - 16 October 2019 through 19 October 2019

ER -

EFFICACY AND SAFETY OF IMMUNOGLOBULIN CAPRYLATE/CHROMATOGRAPHY PURIFIED (IGIV-C) IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATIONS: A MULTICENTER, PROSPECTIVE, OPEN-LABEL, NONCONTROLLED CLINICAL TRIAL

Keywords*

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this